Dm. Zisterer et al., PK-11195 REDUCES THE BRAIN AVAILABILITY OF LINDANE IN RATS AND THE CONVULSIONS INDUCED BY THIS NEUROTOXIC AGENT, Life sciences, 57(25), 1995, pp. 2359-2364
Citations number
18
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
The effect of pretreatment with PK 11195, a ligand of the 'peripheral-
type' benzodiazepine receptor (PER), on convulsions induced by lindane
(gamma-hexachlorocyclohexane, gamma-HCH) in rats was examined, to det
ermine whether the mechanism of this convulsant activity may be mediat
ed through the PER. PK 11195 elicited a protective effect against the
convulsant activity of orally administered lindane. It reduced the fre
quency of animals exhibiting convulsions and delayed the time to onset
of these seizures. The concentration of lindane in the brain was foun
d to be significantly lower in PK 11195 pretreated rats and a high cor
relation between blood and brain lindane concentrations was obtained.
When similar experiments were repeated with alpha-HCH, a non-convulsan
t isomer of HCH, brain and blood concentrations were again found to be
significantly reduced in PK 11195 pretreated animals. We conclude tha
t the 'anticonvulsant' action of PK 11195 was not due to an interactio
n of PK 11195 and lindane on common CNS target sites, but by an action
of PK 11195 on the gastrointestinal tract of the animal, delaying the
absorption of lindane into the bloodstream.